Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Droste

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2019
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German SurveyUlf Elbelt, Sven M Schlaffer, Michael Buchfelder, et al.
Clinical Endocrinology|March 26, 2018
Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYNElena Valassi, Richard Feelders, Dominique Maiter, et al.
European Journal of Endocrinology|September 4, 2019
High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registryElena Valassi, Antoine Tabarin, Thierry Brue, et al.
European Journal of Endocrinology|February 15, 2018
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYNElena Valassi, Holger Franz, Thierry Brue, et al.
European Journal of Endocrinology|April 6, 2017
Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYNElena Valassi, Holger Franz, Thierry Brue, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2019
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German SurveyUlf Elbelt, Sven M Schlaffer, Michael Buchfelder, et al.
Clinical Endocrinology|March 26, 2018
Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYNElena Valassi, Richard Feelders, Dominique Maiter, et al.
European Journal of Endocrinology|September 4, 2019
High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registryElena Valassi, Antoine Tabarin, Thierry Brue, et al.
European Journal of Endocrinology|February 15, 2018
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYNElena Valassi, Holger Franz, Thierry Brue, et al.
European Journal of Endocrinology|April 6, 2017
Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYNElena Valassi, Holger Franz, Thierry Brue, et al.
Pageof 3